• 1
    Qureshi AIM, Suarez JIM, Yahia AMM, Mohammad YM, Uzun GM, Suri MF, Zaidat OOM, Ayata CM, Ali ZM, Wityk RJM. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review. Crit Care Med 2003; 31: 2727.
  • 2
    Hacke W, Schwab S, Horn M, Spranger M, de Georgia M, von Kummer R. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53: 30915.
  • 3
    Berrouschot J, Rossler A, Koster J, Schneider D. Mechanical ventilation in patients with hemispheric ischemic stroke. Crit Care Med 2000; 28: 295661.
  • 4
    Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, Chalela JA, Abbur R, McGrade H, Christou I, Krieger DW. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001; 32: 211723.
  • 5
    de Jong G, van Raak L, Kessels F, Lodder J. Stroke subtype and mortality. A follow-up study in 998 patients with a first cerebral infarct. J Clin Epidemiol 2003; 56: 2628.
  • 6
    Meijer R, Ihnenfeldt DS, van Limbeek J, Vermeulen M, de Haan RJ. Prognostic factors in the subacute phase after stroke for the future residence after six months to one year. A systematic review of the literature. Clin Rehabil 2003; 17: 51220.
  • 7
    Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003; 16: 1419.
  • 8
    Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Aspects Study Group. Alberta Stroke Programme early CT score. Lancet 2000; 355: 16704.
  • 9
    Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment--systematic review. Radiology 2005; 235: 44453.
  • 10
    Barber PA, Demchuk AM, Zhang J, Kasner SE, Hill MD, Berrouschot J, Schmutzhard E, Harms L, Verro P, Krieger D. Computed tomographic parameters predicting fatal outcome in large middle cerebral artery infarction. Cerebrovasc Dis 2003; 16: 2305.
  • 11
    Ikeda K, Kano O, Ito H, Kawase Y, Iwamoto K, Sato R, Sekine T, Nagata R, Nakamura Y, Hirayama T, Iwasaki Y. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2008; 70: 1576; author reply 1576–7.
  • 12
    von Kummer R, Bourquain H, Bastianello S, Bozzao L, Manelfe C, Meier D, Hacke W. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001; 219: 95100.
  • 13
    Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J. Improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25: 22206.
  • 14
    Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007; 369: 2938.
  • 15
    Wardlaw JM, Keir SL, Seymour J, Lewis S, Sandercock PA, Dennis MS, Cairns J. What is the best imaging strategy for acute stroke? Health Technol Assess 2004; 8: ix-x, 1-180.
  • 16
    Michel P, Odier C, Rutgers M, Reichhart M, Maeder P, Meuli R, Wintermark M, Maghraoui A, Faouzi M, Croquelois A, Ntaios G. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke 2010; 41: 24918.
  • 17
    Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 1993; 24: 3541.
  • 18
    Committee TESOEECatEW. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 (update from 16.03.2009 on http://www.Eso-stroke.Org). Cerebrovasc Dis 2008; 25: 457507.
  • 19
    Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke 1981; 12: 4747.
  • 20
    Yoshimoto T, Ogawa A, Seki H, Kogure T, Suzuki J. Clinical course of acute middle cerebral artery occlusion. J Neurosurg 1986; 65: 32630.
  • 21
    Appelros P, Nydevik I, Seiger A, Terent A. Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke 2002; 33: 235762.
  • 22
    Spengos K, Tsivgoulis G, Manios E, Synetou M, Vassilopoulou S, Zakopoulos N, Vassilopoulos D, Vemmos KN. Stroke etiology is associated with symptom onset during sleep. Sleep 2005; 28: 2338.
  • 23
    Kramer AH, Zygun DA. Anemia and red blood cell transfusion in neurocritical care. Crit Care 2009; 13: R89.
  • 24
    Ning YP, Kanai K, Tomiyama H, Li Y, Funayama M, Yoshino H, Sato S, Asahina M, Kuwabara S, Takeda A, Hattori T, Mizuno Y, Hattori N. Park9-linked parkinsonism in eastern Asia: mutation detection in atp13a2 and clinical phenotype. Neurology 2008; 70: 14913.
  • 25
    Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with prourokinase by using ASPECTS. Stroke 2003; 34: 192531.
  • 26
    Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol A, O’Reilly C, Hudon ME, Hu WY, Coutts SB, Barber PA, Watson T, Roy J, Demchuk AM. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008; 3: 2306.
  • 27
    Marti-Fabregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvis R, Cocho D, Roquer J, Rodriguez A, Garcia MD, Molina-Porcel L, Diaz-Manera J, Marti-Vilalta JL. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004; 35: 111721.
  • 28
    Fuentes B, Martinez-Sanchez P, Diez-Tejedor E. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovasc Dis 2009; 27(Suppl. 1): 12633.
  • 29
    Dessein PH, Joffe BI, Stanwix AE. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study. Arthritis Res 2002; 4: R12.
  • 30
    Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med 2009; 2: 30.
  • 31
    Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 21522.
  • 32
    Michel P, Arnold M, Hungerbuhler HJ, Muller F, Staedler C, Baumgartner RW, Georgiadis D, Lyrer P, Mattle HP, Sztajzel R, Weder B, Tettenborn B, Nedeltchev K, Engelter S, Weber SA, Basciani R, Fandino J, Fluri F, Stocker R, Keller E, et al. Decompressive craniectomy for space occupying hemispheric and cerebellar ischemic strokes: Swiss recommendations. Int J Stroke 2009; 4: 21823.
  • 33
    Sato I, Wu S, Ibarra MC, Hayashi YK, Fujita H, Tojo M, Oh SJ, Nonaka I, Noguchi S, Nishino I. Congenital neuromuscular disease with uniform type 1 fiber and ryr1 mutation. Neurology 2008; 70: 11422.
  • 34
    Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kohrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Stroke 2008; 39: 331622.
  • 35
    Schonewille WJ, Wijman CA, Michel P, Rueckert CM, Weimar C, Mattle HP, Engelter ST, Tanne D, Muir KW, Molina CA, Thijs V, Audebert H, Pfefferkorn T, Szabo K, Lindsberg PJ, de FG, Kappelle LJ, Algra A. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009; 8: 72430.
  • 36
    Adams I. Comparison of synaptic changes in the precentral and postcentral cerebral cortex of aging humans: a quantitative ultrastructural study. Neurobiol Aging 1987; 8: 20312.
  • 37
    Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 2136.
  • 38
    Boysen G, Christensen H. Stroke severity determines body temperature in acute stroke. Stroke 2001; 32: 41317.
  • 39
    Ntaios G, Egli M, Faouzi M, Michel P. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010; 41: 236670.
  • 40
    Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 2011; 10: 47180.
  • 41
    Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60: 6205.
  • 42
    Rey V, Faouzi M, Huchmand-Zadeh M, Michel P. Stroke initial severity and outcome relative to insurance status in a universal health care system in Switzerland. Eur J Neurol 2011; 18: 10947.
  • 43
    Ottman R, Rosenberger L, Bagic A, Kamberakis K, Ritzl EK, Wohlschlager AM, Shamim S, Sato S, Liew C, Gaillard WD, Wiggs E, Berl MM, Reeves-Tyer P, Baker EH, Butman JA, Theodore WH. Altered language processing in autosomal dominant partial epilepsy with auditory features. Neurology 2008; 71: 197380.
  • 44
    Ntaios G, Faouzi M, Michel P. The effect of thrombolysis on short-term improvement depends on initial stroke severity. J Neurol 2012; 259: 5249.
  • 45
    Ingall TJ, O’Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, Christianson TJ. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 2004; 35: 241824.
  • 46
    Mattle HP, Arnold M, Georgiadis D, Baumann C, Nedeltchev K, Benninger D, Remonda L, von Büdingen C, Diana A, Pangalu A, Schroth G, Baumgartner RW. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008; 39: 37983.
  • 47
    Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, Ebinger M, Barber PA, Bladin C, Donnan GA, Davis SM. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30: 121425.
  • 48
    Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 24854.
  • 49
    Lakhan SE, Bagchi S, Hofer M. Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med 2010; 3: 22.
  • 50
    Ntaios G, Abatzi C, Alexandrou M, Chatzopoulos S, Egli M, Ruiz J, Bornstein N, Michel P. Persistent hyperglycemia at 24–48 hours in acutely hyperglycemic stroke patients is not associated with worse functional outcome. Cerebrovasc Dis 2011; 32: 5616.
  • 51
    Kim JT, Park MS, Choi KH, Nam TS, Choi SM, Lee SH, Kim BC, Kim MK, Cho KH. The CBV-ASPECT score as a predictor of fatal stroke in a hyperacute state. Eur Neurol 2010; 63: 35763.
  • 52
    Odier C, Michel P. Recanalization and Collaterals Predict Outcome in Proximal MCA Occlusion, but neither Penumbra nor Core of Stroke [poster]. Int Stroke Conf 2011; Los Angeles.